U.S. Markets closed

LogicBio planning first trial of gene editing treatment for children

Allison DeAngelis
LogicBio planning first trial of gene editing treatment for children

The four-year-old biotech is planning to seek FDA approval for its first clinical trial by the end of the year, executives told the Business Journal this week.